Female Infertility and Cardiovascular Risk - A Hype or an Underestimated Reality?

Author(s): Julia K. Bosdou*, Panagiotis Anagnostis, George T. Lainas, Efstratios M. Kolibianakis

Journal Name: Current Pharmaceutical Design

Volume 26 , Issue 43 , 2020


Become EABM
Become Reviewer
Call for Editor

Abstract:

Infertility may be an early indicator of later-life health risk development, such as cardiovascular disease (CVD), the leading cause of death globally. Various infertility-associated factors such as female age, polycystic ovarian syndrome, endometriosis and metabolic syndrome are also risk factors for CVD. Whether there is a real association between female infertility and CVD, given that common pathways lead to both entities, or since both female infertility and CVD share a common basis, needs to be further investigated. If such an association is confirmed, infertile women might benefit from the initiation of preventive strategies aiming to control CVD risk factors. Thus, female infertility may represent an early indicator of future CVD and concomitantly a unique opportunity to identify women at increased risk for developing CVD. It is therefore imperative that large population- based studies are performed to elucidate this issue further and promote public awareness, if necessary.

Keywords: Female infertility, cardiovascular disease, arterial hypertension, diabetes mellitus, dyslipidemia, CVD.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 26
ISSUE: 43
Year: 2020
Published on: 22 December, 2020
Page: [5551 - 5555]
Pages: 5
DOI: 10.2174/1381612826666200821114552
Price: $65

Article Metrics

PDF: 14